149 related articles for article (PubMed ID: 21806327)
1. PET and PET/CT in radiation treatment planning for prostate cancer.
Pinkawa M; Eble MJ; Mottaghy FM
Expert Rev Anticancer Ther; 2011 Jul; 11(7):1033-9. PubMed ID: 21806327
[TBL] [Abstract][Full Text] [Related]
2. Volumetric modulated arc therapy planning for primary prostate cancer with selective intraprostatic boost determined by 18F-choline PET/CT.
Kuang Y; Wu L; Hirata E; Miyazaki K; Sato M; Kwee SA
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1017-25. PubMed ID: 25832692
[TBL] [Abstract][Full Text] [Related]
3. Intensity modulated radiation therapy dose painting for localized prostate cancer using ¹¹C-choline positron emission tomography scans.
Chang JH; Lim Joon D; Lee ST; Gong SJ; Anderson NJ; Scott AM; Davis ID; Clouston D; Bolton D; Hamilton CS; Khoo V
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e691-6. PubMed ID: 22658218
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography for radiation treatment planning.
Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
[TBL] [Abstract][Full Text] [Related]
5. Intensity-modulated radiotherapy of prostate cancer with simultaneous integrated boost after molecular imaging with 18F-choline-PET/CT : Clinical results and quality of life.
Schlenter M; Berneking V; Krenkel B; Mottaghy FM; Vögeli TA; Eble MJ; Pinkawa M
Strahlenther Onkol; 2018 Jul; 194(7):638-645. PubMed ID: 29511777
[TBL] [Abstract][Full Text] [Related]
6. PET/CT and radiotherapy in prostate cancer.
De Jong IJ; De Haan TD; Wiegman EM; Van Den Bergh AC; Pruim J; Breeuwsma AJ
Q J Nucl Med Mol Imaging; 2010 Oct; 54(5):543-52. PubMed ID: 20927021
[TBL] [Abstract][Full Text] [Related]
7. Carbon-11 acetate PET/CT based dose escalated IMRT in prostate cancer.
Seppälä J; Seppänen M; Arponen E; Lindholm P; Minn H
Radiother Oncol; 2009 Nov; 93(2):234-40. PubMed ID: 19766336
[TBL] [Abstract][Full Text] [Related]
8. Intensity-modulated radiotherapy for prostate cancer implementing molecular imaging with 18F-choline PET-CT to define a simultaneous integrated boost.
Pinkawa M; Holy R; Piroth MD; Klotz J; Nussen S; Krohn T; Mottaghy FM; Weibrecht M; Eble MJ
Strahlenther Onkol; 2010 Nov; 186(11):600-6. PubMed ID: 20936457
[TBL] [Abstract][Full Text] [Related]
9. Dose-escalation using intensity-modulated radiotherapy for prostate cancer - evaluation of quality of life with and without (18)F-choline PET-CT detected simultaneous integrated boost.
Pinkawa M; Piroth MD; Holy R; Klotz J; Djukic V; Corral NE; Caffaro M; Winz OH; Krohn T; Mottaghy FM; Eble MJ
Radiat Oncol; 2012 Jan; 7():14. PubMed ID: 22289620
[TBL] [Abstract][Full Text] [Related]
10. Dose-escalation using intensity-modulated radiotherapy for prostate cancer--evaluation of the dose distribution with and without 18F-choline PET-CT detected simultaneous integrated boost.
Pinkawa M; Attieh C; Piroth MD; Holy R; Nussen S; Klotz J; Hawickhorst R; Schäfer W; Eble MJ
Radiother Oncol; 2009 Nov; 93(2):213-9. PubMed ID: 19717197
[TBL] [Abstract][Full Text] [Related]
11. PET/CT Dose Planning for Volumetric Modulated Arc Radiation Therapy (VMAT) -Comparison with Conventional Approach in Advanced Prostate Cancer Patients.
Kairemo K; Rasulova N; Kiljunen T; Partanen K; Kangasmäki A; Joensuu T
Curr Radiopharm; 2015; 8(1):2-8. PubMed ID: 25882786
[TBL] [Abstract][Full Text] [Related]
12. Current standards and future directions for prostate cancer radiation therapy.
Pinkawa M; Schoth F; Böhmer D; Hatiboglu G; Sharabi A; Song D; Eble MJ
Expert Rev Anticancer Ther; 2013 Jan; 13(1):75-88. PubMed ID: 23259429
[TBL] [Abstract][Full Text] [Related]
13. ¹⁸F-choline positron emission tomography/computed tomography-driven high-dose salvage radiation therapy in patients with biochemical progression after radical prostatectomy: feasibility study in 60 patients.
D'Angelillo RM; Sciuto R; Ramella S; Papalia R; Jereczek-Fossa BA; Trodella LE; Fiore M; Gallucci M; Maini CL; Trodella L
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):296-302. PubMed ID: 25084612
[TBL] [Abstract][Full Text] [Related]
14. Planning of External Beam Radiotherapy for Prostate Cancer Guided by PET/CT.
von Eyben FE; Kairemo K; Kiljunen T; Joensuu T
Curr Radiopharm; 2015; 8(1):19-31. PubMed ID: 25808958
[TBL] [Abstract][Full Text] [Related]
15. Influence of (11)C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancer.
Souvatzoglou M; Krause BJ; Pürschel A; Thamm R; Schuster T; Buck AK; Zimmermann F; Molls M; Schwaiger M; Geinitz H
Radiother Oncol; 2011 May; 99(2):193-200. PubMed ID: 21620494
[TBL] [Abstract][Full Text] [Related]
16. Choline PET/CT for imaging prostate cancer: an update.
Kitajima K; Murphy RC; Nathan MA
Ann Nucl Med; 2013 Aug; 27(7):581-91. PubMed ID: 23632880
[TBL] [Abstract][Full Text] [Related]
17. Clinical evidence on PET/CT for radiation therapy planning in prostate cancer.
Picchio M; Giovannini E; Crivellaro C; Gianolli L; di Muzio N; Messa C
Radiother Oncol; 2010 Sep; 96(3):347-50. PubMed ID: 20708811
[TBL] [Abstract][Full Text] [Related]
18. Image-guided intensity-modulated radiotherapy of prostate cancer: Analysis of interfractional errors and acute toxicity.
Rudat V; Nour A; Hammoud M; Alaradi A; Mohammed A
Strahlenther Onkol; 2016 Feb; 192(2):109-17. PubMed ID: 26545764
[TBL] [Abstract][Full Text] [Related]
19. Volumetric arc therapy and intensity-modulated radiotherapy for primary prostate radiotherapy with simultaneous integrated boost to intraprostatic lesion with 6 and 18 MV: a planning comparison study.
Ost P; Speleers B; De Meerleer G; De Neve W; Fonteyne V; Villeirs G; De Gersem W
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):920-6. PubMed ID: 20675077
[TBL] [Abstract][Full Text] [Related]
20. PET-CT for treatment planning in prostate cancer.
Picchio M; Crivellaro C; Giovacchini G; Gianolli L; Messa C
Q J Nucl Med Mol Imaging; 2009 Apr; 53(2):245-68. PubMed ID: 19293771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
